MGMT and central nervous system cancer: We next tested the three-dimensional growth of T98 and LN18 glioma cells, which are additional high MGMT-expressing GBM cell lines (Sak et al., 2019) transfected with anti-MGMT siRNA or non-targeting siRNA (Supplementary Figure 1).